fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 7 Oct 2026

HINDUNILVR, full dossier

Hindustan Unilever Limited has completed the acquisition of the balance 49% shares of Zywie Ventures Private Limited for a total consideration of INR 824 Crores.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Hindustan Unilever Limited has completed the acquisition of the balance 49% shares of Zywie Ventures Private Limited for a total consideration of INR 824 Crores.

bseindia.com13 Feb 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Hindustan Unilever

₹1,895.20

▲ +3.09%

Close (EOD), as of 6 Oct 2026 · source

Hindustan Unilever: results, dividends, orders, the full cited record →

More on Hindustan Unilever

Hindustan Unilever Limited announced its results for the quarter ended 30th September 2025, reporting a consolidated Underlying Sales Growth of 2% and a flat Underlying Volume Growth.

7 Oct 2026 · 1 publisher

Hindustan Unilever Ltd (HUL) has launched Horlicks Protein in ready-to-drink and powder formats.

4 Oct 2026 · 1 publisher

Hindustan Unilever (HUL) is trading near a five-year low.

30 Sep 2026 · 1 publisher

NSE shares debuted at ₹1,800 on September 24, rising to an intraday high of ₹1,878, and with a market capitalization of ₹4.63 lakh crore, NSE became the ninth-largest listed company in India.

25 Sep 2026 · 1 publisher

Hindustan Unilever Ltd.'s market value has fallen to about 35% of parent Unilever Plc's, from as much as 70% four years ago.

23 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.